Adam Steensberg
- Role
-
President and Chief Executive Officer
- Location
-
Søborg, Denmark
Experience
Adam was appointed to the position of CEO at Zealand Pharma in March 2022 and has 20+ years of experience in both the private and public sectors. Adam has led a significant transformation of Zealand and period of growth for the company. Prior to being appointed CEO, Adam served for several years as Zealand’s Chief Medical Officer and Head of Research & Development and was responsible for the company’s R&D strategy and portfolio of drug candidates. Prior to joining Zealand, Adam led clinical research teams as medical director at Novo Nordisk and worked as a clinician at Rigshospitalet, University of Copenhagen.
His was also as a medical and scientific advisor in the areas of endocrinology, cardiology, gastroenterology and rheumatology, and has significant experience of leading regulatory strategies.
Adam is a former Board Member at DANISH BIO - DANSK BIOTEK.
Education
Adam is a certified medical doctor and holds a Doctor of Medical Sciences degree (D.M.Sc./dr.med.) from the University of Copenhagen, Denmark, and an MBA from IMD, Switzerland. Adam has published more than 45 peer-reviewed scientific papers in renowned international journals.
